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Abstract
Background: Testing and treatment for Helicobacter pylori has become widely accepted as the approach of choice
for patients with chronic dyspepsia but no alarming features. We evaluated H. pylori status among outpatients with
uninvestigated dyspepsia in Kuwait.
Methods: A prospectively collected database for 1035 patients who had undergone
13C-urea breath tests (UBT) for
various indications was reviewed for the period from October 2007 to July 2009. The status of H. pylori in dyspeptic
patients was determined by UBT.
Results: Among the 362 patients who had undergone UBT for uninvestigated dyspepsia, 49.7% were positive for
H. pylori (95% CI = 44%-55%) and the percentage increased with age (35.8% at 20-29 years, 95% CI = 25.4% -
47.2%; 59.3% at 30-39 years, 95% CI = 48.5% - 69.5%) (P = 0.013). The prevalence of H. pylori was 42.6% among
Kuwaitis (95% CI = 35%-50%) and 57.6% (95% CI = 49.8%-65%) among expatriates (p = 0.004). The prevalence
among males was 51.3%, while in females it was 48.6%.
Conclusions: Almost half of the patients with dyspeptic symptoms in Kuwait were positive for H. pylori, though
the prevalence varied with age and was higher among expatriates. The American Gastroenterology Association
guidelines recommending testing and treatment for H. pylori for patients with uninvestigated dyspepsia should be
endorsed in Kuwait.
Background
Helicobacter pylori (H. pylori) is causally related to ser-
ious disorders of the upper gastrointestinal tract in
adults and children. Over 50% of the world’s population
is infected, with the highest prevalence in developing
countries [1]. Although some reports have shown that
H. pylori-positive patients tend to have dyspepsia [2],
the relationship between H. pylori and dyspepsia
remains controversial. The 2005 American College of
Gastroenterology (ACG) guidelines for the management
of dyspepsia recommend testing for H. pylori infection
among dyspeptic patients without alarming features as
the preferred, most cost-effective approach [3].
It is important to recognize the high prevalence of H.
pylori among dyspeptic patients in Kuwait from the stand-
point of eradication cost. In 1998, 88.5% of patients in
Kuwait with dyspeptic symptoms who were referred for
endoscopy proved H. pylori-positive [4]. Accordingly, the
testing and treatment strategy recommended by the ACG
would be the most cost-effective approach to patients with
uninvestigated dyspepsia. Proper guidelines for dyspepsia
can only be established when the prevalence of H. pylori
among dyspeptic patients is clarified. The present study
evaluated H. pylori status among outpatients with dyspep-
sia at a tertiary referral center in Kuwait.
Methods
Subjects
We performed a retrospective analysis on the
13C-urea
breath test (
13C-UBT) database that had been prospectively
collected for the period from October 2007 to July 2009.
The database included each patient’s age, sex, weight, pre-
vious treatment for H. pylori, previous endoscopy, indication
for UBT, and the
13C-UBT result. The Ethics Committee of
the Kuwait Ministry of Health approved this study.
Evaluation of H. pylori status with
13C-UBT
Patients aged 9 years or over ingested 100 mg of
13C-urea
(Isomed, Madrid, Spain) in 75 ml of water after an 8-hour
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any medium, provided the original work is properly cited.fast, then rinsed their mouths three times with tap water
to minimize interference from oral urease-producing
bacteria. Breath samples were collected into 250-ml sili-
conized vacutainers at baseline and at 30 min after the
intake of
13C-urea. The
13CO2/
12CO2 ratio was measured
using an isotope ratio mass spectrometer (ABCA-G;
Europa Scientific, Cheshire, UK). The increase in the
molar fraction of tracer
13CO2 at 30 min compared with
the baseline value was expressed as delta per ml (‰). In
this study we took 3.5‰ as the cutoff value.
Statistics
We performed all statistical analyses using the SPSS sta-
tistical package for Windows; the 95% confidence inter-
val for key proportions was calculated using the exact
binomial distribution. The chi square test was used to
test the differences in proportion when appropriate; dif-
ferences with P < 0.05 were deemed significant.
Results
The prospectively collected database for 1035 patients
who had undergone a
13C-urea breath test for various
indications was reviewed for the period from October
2007 to July 2009. In 362 of these 1035 patients (186
males and 176 females, mean age 38 years, range 10-80
years), UBT had been performed for uninvestigated dys-
pepsia. These patients were classed by nationality as
Kuwaitis and expatriates, and according to age into
young (less than 30 years), middle-aged (from 30 to 49
years) and elderly (more than 50 years). The overall pre-
valence of H. pylori among the 362 dyspeptic patients
was 49.7% (95%CI: 44%- 55%). Figure (1) shows the var-
iation of prevalence with age. The prevalence was 42.6%
(95%CI: 35.5%- 50.0%) among Kuwaitis and 57.6% (95%
CI: 49.8%- 65.0%) among expatriates (p = 0.004).
Among the dyspeptic Kuwaiti patients, H. pylori was
significantly more prevalent among young females than
males (38% Vs 10.5%, p =0 . 0 0 8 ) .H o w e v e r ,t h e r ew a s
no sex difference in overall prevalence (females 43.2%,
males 42.2%) (Table 1). Among the dyspeptic expatriate
patients, the overall prevalence of H. pylori was lower
among females (40% vs 66%, p = 0.002) (Table 2).
Thirty-three patients (9%) infected with H. pylori
needed upper endoscopy compared to 42 (6.2%) who
were not infected. There were no statistically significant
differences with age in the rate of endoscopy.
Discussion
Dyspepsia remains a costly, chronic condition, and drug
costs in particular continue to increase rapidly [5]. In
many cases, the symptoms are of short duration or mild
in severity and are self-managed [6]. The optimal man-
agement strategy for patients aged 55 years or younger
who present with new-onset dyspepsia and no alarming
features has been dominated by testing for H. pylori
and treating all positive cases empirically with antimi-
crobial therapy. However, other strategies have been
practiced such as empirical medical therapy (e.g. antise-
cretory agents), subsequent investigation being limited
to failures, or immediate evaluation by upper endoscopy
in all cases, therapy being targeted on the basis of the
results [7].
The H. pylori testing and treatment approach is likely
to be more beneficial than other strategies in infected
patients, and the impact of this strategy is likely to be
small if the infection is not very prevalent [7]. In addi-
tion, cost-effectiveness studies suggest that a choice of
noninvasive testing should be based on the prevalence
of infection in the community. In low and intermediate
prevalence situations, the stool antigen test or urea
breath test dominate [8]. The higher costs of these tests
are offset by their accuracy. Accordingly, it is clear that
determining the prevalence of H. pylori i n f e c t i o ni nt h e
community is fundamental to deciding the most cost-
Figure 1 Prevalence of H. pylori in 362 dyspeptic patients.
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gated dyspepsia.
In 1998, 88.5% of patients in Kuwait with dyspeptic
symptoms who were referred for endoscopy proved H.
pylori- p o s i t i v e[ 4 ] .H o w e v e r ,t h ep r e v a l e n c eo fH. pylori
infection has continued to decline dramatically, as has
the identification of peptic ulcer disease [9]. Moreover,
the prevalence of H. pylori infection differs widely
among countries and by age and race [10]. Hence, our
present study was designed to evaluate the prevalence of
H. pylori infection among new dyspepsia patients and to
stratify them by age and race in order to apply the
appropriate management strategy.
The overall prevalence of H. pylori among the 362 dys-
peptic patients in our study was 49.7%, though it varied
with age, race and sex. This prevalence is considered
intermediate. On the basis of this study, therefore, the
choice of noninvasive test in our community should be
either the urea breath test or stool antigen test, both of
which have been shown to be accurate for the initial
diagnosis of H. pylori infection and for confirming eradi-
cation [7]. The urea breath test is widely available in
Kuwait in both governmental and private sectors, but the
stool antigen test is not yet available. Both tests require
discontinuation of PPI for two weeks because the drugs
used inhibit urease, leading to false negative results [11].
In view of the current prevalence of H. pylori infection
in Kuwait, the testing and treatment approach is likely
to be the most cost-effective strategy for evaluating
patients with dyspepsia. This policy would decrease the
work-load on endoscopy centers, lower the costs and
decrease the rate of complications associated with upper
endoscopy. Moreover, the management approach can
easily be established at primary care centers and general
hospital clinics. This would decrease the number of
patients in subspecialty clinics, allowing more time for
the specialists to manage more complex gastrointestinal
diseases.
Our study did not evaluate the relief of symptoms or
healing rates in the dyspepsia patients after H. pylori
infection was treated. Consequently, it did not confirm
the usefulness of the testing and treatment strategy in
clinical practice for relief of symptoms. Furthermore, in
patients older than 50 years, direct endoscopy could be
an alternative strategy for detecting gastroduodenal
pathology, which may require close follow-up in this
patient age group.
After stratifying the patients according to race, age and
sex, it was evident that there was significantly more
H. pylori infection among the expatriates (57.6% vs 42.6%,
p = 0.004). Since most of the expatriates belong to either
low or intermediate socioeconomic classes, a cost-effective
approach to the management of dyspepsia would benefit
this category of patients. Our data also indicated that
among dyspeptic expatriates, H. pylori was less prevalent
overall among female patients (40% vs 66%, p = 0.002).
This sex difference in prevalence may be attributed to
numerous epidemiological factors including country of
origin, socioeconomic class, place of birth and ethnicity.
Among the dyspeptic Kuwaiti patients, on the other
hand, H. pylori was significantly more prevalent among
young females than males (38% vs 10.5%, p = 0.008), but
there was no sex difference overall (females 43.2% Vs males
42.2%) (Table 1). This indicates that female Kuwaiti patients
acquire H. pylori infection at a younger age than males,
which could be translated clinically to a more aggressive
disease associated with long duration of infection.
In a population-based study from Norway [12], the dis-
tribution of H. pylori infection with regard to dyspepsia
i nm e na n dw o m e nw a su n e v e n .M o r e o v e r ,t h ep r e v a -
lence of H. pylori infection had decreased independently
of dyspepsia, especially in younger age groups. These
findings are broadly similar to those of our present study,
questioning our understanding of the causal relationship
between dyspepsia and H. pylori infection.
Conclusions
The present study establishes the prevalence of H. pylori
infection in dyspeptic patients in Kuwait. It also
describes the variation in prevalence with age, sex and
country of origin. Our findings support the American
Gastroenterology Association guidelines, recommending
testing and treatment for H. pylori infection in patients
with new-onset dyspepsia as the most cost-effective
approach.
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